Clinical Trial Update: Evaluation of Efficacy and Safety of SDN-037 [Phase 3]

View source ↗

Summary

Phase 3 trial completed evaluating the efficacy and safety of SDN-037 for inflammation and pain after ocular surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation and Pain Associated with Ocular Surgery

Drugs mentioned

• SDN-037

Snippet

Sponsor: Sun Pharma Advanced Research Company Limited | Conditions: Inflammation and Pain Associated With Ocular Surgery | Phase 3 | Status: COMPLETED | Results posted: 2021-05-17